NewEdge Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$84.4M Buy
1,318,329
+441,257
+50% +$29M 0.25% 74
2026
Q1
$62.4M Sell
877,072
-648
-0.1% -$51.1K 0.23% 82
2025
Q4
$72M Buy
877,720
+860,403
+4,969% +$67M 0.26% 73
2025
Q3
$1.3M Sell
17,317
-145
-0.8% -$10.8K 0.01% 1249
2025
Q2
$1.29M Sell
17,462
-279
-2% -$19.4K 0.01% 1147
2025
Q1
$1.43M Sell
17,741
-166
-0.9% -$14.3K 0.01% 1005
2024
Q4
$1.4M Buy
17,907
+715
+4% +$60.8K 0.01% 998
2024
Q3
$1.61M Buy
17,192
+2,547
+17% +$214K 0.01% 891
2024
Q2
$1.14M Buy
14,645
+775
+6% +$63.2K 0.01% 1006
2024
Q1
$1.26M Buy
13,870
+2,565
+23% +$213K 0.01% 881
2023
Q4
$856K Buy
11,305
+1,454
+15% +$102K 0.01% 1015
2023
Q3
$670K Sell
9,851
-8,208
-45% -$597K 0.01% 1046
2023
Q2
$1.47M Buy
18,059
+388
+2% +$31K 0.02% 706
2023
Q1
$1.44M Buy
+17,671
New +$1.26M 0.02% 646

Other funds holding GEHC

NewEdge Advisors's GEHC Position: Q2 2026 in Review

NewEdge Advisors increased its GE HealthCare (GEHC) stake by 50% in Q2 2026, buying an estimated $29M and bringing the position to 1,318,329 shares worth $84.4M. The position accounts for 0.25% of the portfolio, ranked #74.

NewEdge Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • NewEdge Advisors held 1,318,329 shares of GE HealthCare worth $84.4M as of Q2 2026.
  • NewEdge Advisors bought 441,257 GE HealthCare shares in Q2 2026, an estimated $29M.
  • GE HealthCare made up 0.25% of NewEdge Advisors's portfolio in Q2 2026, its #74 holding.
  • NewEdge Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.